Here is the latest shareholding Pattern of MANGALAM DRUGS. For more details, see the MANGALAM DRUGS financial fact sheet and MANGALAM DRUGS share price. For a sector overview, read our pharmaceuticals sector report.
No. of Mths Qtr. Ending |
3
Jun-22 |
3
Sep-22 |
3
Dec-22 |
3
Mar-23 |
3
Jun-23 |
3
Sep-23 |
3
Dec-23 |
3
Mar-24 |
||
---|---|---|---|---|---|---|---|---|---|---|
Indian Promoters | % | 50.42 | 50.42 | 50.32 | 50.32 | 50.32 | 50.32 | 50.32 | 50.32 | |
Foreign Promoters | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Promoters | % | 50.42 | 50.42 | 50.32 | 50.32 | 50.32 | 50.32 | 50.32 | 50.32 | |
Mutual Funds | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Financial institution/Banks/Insurance | % | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Government | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
FII | % | 0.10 | 0.10 | 0.10 | 0.10 | 0.10 | 0.10 | 0.10 | 0.26 | |
Other | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Institution | % | 0.11 | 0.10 | 0.10 | 0.10 | 0.10 | 0.10 | 0.10 | 0.26 | |
Bodies Corporate | % | 1.89 | 2.12 | 1.97 | 1.93 | 1.93 | 2.02 | 2.04 | 2.31 | |
Individuals | % | 44.18 | 44.13 | 44.27 | 44.22 | 44.64 | 44.55 | 44.44 | 44.22 | |
NRIs/OCBs | % | 1.34 | 1.33 | 1.21 | 1.26 | 1.16 | 1.18 | 1.32 | 1.15 | |
ADR/GDR | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Others | % | 2.06 | 1.90 | 2.13 | 2.17 | 1.85 | 1.83 | 1.78 | 1.74 | |
Total Non-Institution | % | 49.47 | 49.48 | 49.58 | 49.58 | 49.58 | 49.58 | 49.58 | 49.42 | |
Total Public | % | 50.00 | 50.00 | 50.00 | 50.00 | 50.00 | 50.00 | 50.00 | 50.00 | |
Grand Total | % | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | |
Pledged Promoter Holding | % | 16.97 | 16.22 | 16.65 | 20.93 | 20.04 | 17.52 | 18.08 | 17.58 | |
Subscriber Feature |
More Pharmaceuticals Company Shareholding Pattern: ZYDUS LIFESCIENCES CIPLA DIVIS LABORATORIES SUN PHARMA DR. REDDYS LAB
Indian share markets continued the momentum as the session progressed and ended the higher.